Hinge Health, Inc. engages in the development of technology platform for the treatment of musculoskeletal (MSK) conditions. Its platform addresses a broad spectrum of MSK care, from acute injury to ...

With an average analyst rating of buy, Humana is clearly an analyst favorite. But the analysts could be wrong. Is HUM overvalued at today's price of $225.85? Let's take a closer look at the ...

Shares of Humana Inc. rallied 3.94% to $247.34 Monday, on what proved to be an all-around positive trading session for the ...

Humana has a P/E ratio of 16.4 based on its 12 month trailing earnings per share of $14.17. Considering its future earnings ...

Shares of Humana Inc. HUM shed 1.51% to $249.53 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.07% to 5,659.91 and Dow ...

Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes.

Capture valuable insights into Humana's market standing by understanding ... Revenue Growth: Over the 3M period, Humana showcased positive performance, achieving a revenue growth rate of 10.4 ...

Despite these developments, Humana's stock performance remained flat over the ... added weight to these broader market dynamics rather than countering them. We've identified 2 possible red flags ...

the market reacted positively. In premarket trading, Humana’s stock rose 6.03%, reflecting investor confidence in the company’s robust performance and strategic outlook. According to InvestingPro ...